IVF Embryo Grading: What 4AA, 5AA, 4BB and 5BC Mean

Medically reviewed on 22 July 2026 - Dr. Senai Aksoy
IVF Embryo Grading: What 4AA, 5AA, 4BB and 5BC Mean

Key Takeaways

IVF embryo grading describes how a blastocyst looks under the microscope — an expansion number plus two letters for the inner cell mass and trophectoderm. A 5AA or 4AA usually looks stronger than a 4BB or 5BC, but morphology is not a live-birth guarantee. Age, chromosome status, developmental timing, laboratory assessment, and transfer-related factors all shape the outcome.

Key evidence: ESHRE/Alpha Istanbul Consensus update (2025) Blastocyst quality and reproductive outcomes — multinational study (2023)

On this page

IVF embryo grading: what the lab report really means

When a report lands with codes like 4AA, 4BB or 5BC, it is easy to read it like a school grade. Most patients do. In reality, embryo grading gives embryologists and clinicians a shared language for describing blastocysts and deciding which one to discuss first for transfer or freezing. It helps structure the conversation. It does not, on its own, tell you what will happen.

The familiar Gardner system supplies the number-and-letter code. The 2011 Istanbul consensus gave laboratories common minimum criteria, and the 2025 ESHRE/Alpha update refined them with newer evidence. That shared vocabulary makes day-to-day decisions clearer and helps research from different centres fit together.

Grading is still partly subjective. The same embryo may receive a slightly different grade from a different embryologist or laboratory, so these codes are not standardized test scores for comparing clinics.

No single code carries one universal success rate. Age, chromosomal status, transfer conditions and the rest of the embryo cohort all change the picture. For a broader view of how outcomes vary by age and transfer type, see clinical success rates explained.

IVF embryo grading: 4AA, 3BB, 5BC — Dr Senai Aksoy

What the number means

The number in a grade such as 4AA or 5BC describes blastocyst expansion and hatching stage, as set out in the Gardner blastocyst scoring system.

Think of expansion as a developmental stage, not a stand-alone quality ranking. A higher number may look favorable when similar embryos are assessed at comparable times, but a 5 is not automatically better than a 4. When the embryo was checked, which blastocyst day it reached, and how it re-expands after warming all matter. The number alone does not tell you whether the embryo is chromosomally normal.

What the letters mean

The first letter refers to the inner cell mass (ICM) — the part expected to form the fetus.

The second letter refers to the trophectoderm (TE) — the cells expected to help form the placenta.

For the inner cell mass, A generally means many tightly packed cells, B means several more loosely grouped cells, and C means very few visible cells.

For the trophectoderm, the letters describe the number and organization of the cells in the outer epithelial layer — not the same criteria as for the ICM.

The 2025 ESHRE/Alpha consensus also uses grade D for blastocysts with degenerative features or no clearly visible inner cell mass. That is different from grade C, which may still describe a clinically usable embryo.

Cell-division pattern, fragmentation and the way the blastocyst expands all feed into this snapshot. It remains a snapshot from one moment in development.

So is a 4AA always better than a 3BB or 4BB?

Morphologically, a 4AA or 5AA is usually considered more favorable than a 3BB or 4BB in large cohort studies. The gap is not absolute. A 4BB embryo can still lead to a healthy pregnancy. A beautiful-looking embryo can still fail if it is aneuploid or the uterine environment is unfavorable.

Morphology shifts probability. It is not a promise — and headlines about a “5AA success rate” oversimplify what the lab report is actually showing.

What lower grades do not mean

A lower grade does not automatically mean:

Many successful pregnancies come from BB embryos, and even BC embryos may still be transferred in selected situations.

Why morphology cannot determine chromosome status

Morphology cannot diagnose whether an embryo is euploid or aneuploid. Better-looking embryos may be more likely to be euploid, but appearance is not accurate enough to settle chromosome status on its own. When PGT-A is used for an appropriate clinical indication, its result and its limits are weighed separately from morphology.

Morphology should therefore be interpreted alongside maternal age, the embryo’s developmental day, the rest of the embryo cohort and, when available, appropriately interpreted PGT-A findings.

Other factors that influence success

Even a strong embryo grade does not act in isolation. Outcome also depends on:

The best-looking embryo on paper still needs the right transfer conditions. Day-7 blastocysts may have lower average probabilities than Day-5 embryos, but live births still occur.

Clinical Note

Dr Aksoy’s perspective: what can and cannot be changed

Short answer: When patients ask what they can do to improve an embryo’s grade, the honest answer is that our room for manoeuvre is limited. Morphology matters for implantation and pregnancy potential, but we cannot reliably “upgrade” a grade with a medicine, supplement or laboratory add-on.

Egg and sperm quality matter, as do age, genetics, culture conditions and other biological factors that do not always separate neatly. Our practical job is to tailor stimulation so that we obtain mature oocytes safely, then protect those oocytes and embryos with consistent laboratory care. That work matters. It still cannot rewrite the underlying biology of an egg or sperm cell.

Many supplements, medication changes and laboratory techniques have been tried. Some have a specific role in selected patients, but none has been shown to consistently turn a lower-grade embryo into a higher-grade one. That distinction matters when an IVF add-on is sold as a way to “improve quality”.

A grade changes probability, not possibility. If an embryo remains clinically usable, a lower grade does not reduce its chance to zero. We look at it alongside the rest of the embryo cohort and the patient’s circumstances, rather than dismissing it because the code looks disappointing.

Practical interpretation of common grades

Read the grade together with the blastocyst day. “Day-5 4BB” tells you more than “4BB” alone.

The meaning of each grade changes with the other embryos available and whether genetic results are known. A report showing only one 4BB embryo or one 5AA embryo still needs the wider clinical picture before anyone treats the code as destiny.

FAQ

Does a 5AA embryo have a fixed success rate?

No. A 5AA looks morphologically strong, but live-birth odds still depend on age, euploidy, transfer conditions and the rest of the clinical picture. There is no honest single “5AA success rate” for every patient.

Is a 4BB embryo worth transferring?

Often, yes. A 4BB is a commonly transferred blastocyst with genuine pregnancy potential. The two Bs describe intermediate morphology — not a failed embryo.

Is a 3BB embryo bad?

No. A 3BB is often a reasonable embryo to consider for transfer. Its place in the plan depends on the other embryos and the wider clinical picture.

Does 5BC mean implantation is impossible?

No. It means morphology is less favorable than higher-graded embryos, but pregnancy can still occur.

Is the first letter or second letter more important?

Both matter. In many observational studies, trophectoderm grade has shown the strongest association with live birth, but findings are not completely consistent and neither letter should be read alone. The 2025 ESHRE/Alpha consensus notes that TE is often the strongest predictor in many studies, while the relative importance of ICM, expansion and developmental day is not settled in every context.

If I have a lower grade embryo, should I give up?

No. The decision depends on the full embryo cohort, age, genetic context and transfer history — not on one code in isolation.

Sources

Next step

A question about your own case?

An article can set out the general picture, but not what applies to your own history. If you would like your situation looked at, you can send your questions and any previous reports to the medical team.

Request a medical review

Add as a Preferred Source on Google

You can add draksoyivf.com as one of your preferred health information sources on Google.

Add on Google
Dr. Senai Aksoy

Dr. Senai Aksoy studied and trained in France before returning to Turkey, where he was a founding member of the ICSI team at Sevgi Hospital, Ankara — the country's first ICSI centre (1994-95) — and a co-author on the first Turkish ICSI publications produced in collaboration with the Brussels Van Steirteghem group (Human Reproduction, 1996; PMID 8671323). He helped build the IVF programme at the American Hospital Istanbul and has been running his own fertility practice since 1998.

Verified profiles: PubMed ORCID LinkedIn

The content has been created by Dr. Senai Aksoy and medically approved.